Analyst Ratings for Isleworth Healthcare
Isleworth Healthcare Questions & Answers
The latest price target for Isleworth Healthcare (NASDAQ: ISLE) was reported by Cantor Fitzgerald on August 12, 2022. The analyst firm set a price target for $4.00 expecting ISLE to fall to within 12 months (a possible -59.96% downside). 100 analyst firms have reported ratings in the last year.
The latest analyst rating for Isleworth Healthcare (NASDAQ: ISLE) was provided by Cantor Fitzgerald, and Isleworth Healthcare initiated their overweight rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Isleworth Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Isleworth Healthcare was filed on August 12, 2022 so you should expect the next rating to be made available sometime around August 12, 2023.
While ratings are subjective and will change, the latest Isleworth Healthcare (ISLE) rating was a initiated with a price target of $0.00 to $4.00. The current price Isleworth Healthcare (ISLE) is trading at is $9.99, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.